Abstract

Purpose: Primary hypomagnesemia with secondary hypocalcemia (PHSH) is a genetically defined disease in which there is a malabsorption of magnesium from the intestine. The aim of this research was to encapsulate magnesium into autologous erythrocytes to be used in PHSH patients. A scheme to use a single syringe closed sterile system for the process is proposed. Controlled lysis of erythrocytes and the ability to reseal the loaded erythrocytes were investigated. Method: Suitable concentrations of salt solutions required for making reversible pores and resealing of erythrocytes were identified. For making reversible pores, 0.7% NaCl and 2.3% MgSO4 were used separately. A solution of 3.5% MgSO4 was used as the drug loading solution. After the loading step, the isotonicity for the erythrocytes was restored with 0.9% NaCl and 3.0% MgSO4 solutions separately. The ability to load and reseal erythrocytes were assessed by determining the resulting Mg2+ concentration through Microwave Plasma Atomic Emission Spectrophotometric (MP-AES) analysis. Results: Analysis of results revealed that Mg2+ ions can be successfully loaded into erythrocytes through the formation of reversible pores. Resealing failed with 3.0% MgSO4, but the erythrocytes were successfully resealed with 0.9% NaCl solution. Conclusion: The need for strictly controlled salt solution concentrations for lysis and resealing were identified. In theoretical concentration determinations, the osmotic coefficient had to be taken into account. The study showed the possibility of loading Mg2+ into erythrocytes as a successful drug delivery system.

Highlights

  • Erythrocyte loaded drug delivery system is advantage is the prospect of prolonged being actively investigated currently among release up to the life span of the erythrocyte several prolonged release systems

  • Gastric retentive, sustained or controlled release, and selfemulsifying drug delivery systems are some examples.(1) In this study, erythrocyte loading will be investigated to find out if an inorganic drug could be used as a prolonged release drug delivery system

  • NaCl solutions in different strengths were used because according to literature that is the solution which has widely been used in erythrocyte drugs loading studies

Read more

Summary

Introduction

Erythrocyte loaded drug delivery system is advantage is the prospect of prolonged being actively investigated currently among release up to the life span of the erythrocyte several prolonged release systems. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited. Prolonged release drug delivery systems are innovated to eliminate this cyclical plasma drug concentration levels. Gastric retentive, sustained or controlled release, and selfemulsifying drug delivery systems are some examples.(1) In this study, erythrocyte loading will be investigated to find out if an inorganic drug could be used as a prolonged release drug delivery system

Objectives
Methods
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call